News

2022

company

year

domain

Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock

Evelo Biosciences 05.25.2022

Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Evelo Biosciences 05.12.2022

Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors

Evelo Biosciences 04.21.2022

Evelo Biosciences Announces Appointments of Jose-Carlos Gutiérrez-Ramos and Tonya Williams to Board of Directors

Evelo Biosciences 04.06.2022

Loading Animation
Loading
News Companies
Pioneering Medicines Pioneering Intelligence Preemptive Health & Medicine Flagship Global Engagement Flagship Fellowship Pioneering Social Impact
Content People
About Flagship Process
Join Us Contact Careers Privacy Policy Terms of Use